Centessa Pharmaceuticals Rings the Closing Bell

Published

Centessa Pharmaceuticals (Nasdaq: CNTA) visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Saurabh Saha, M.D., Ph.D., Director & CEO, rings the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now